BU’s Leading Home for Infectious Diseases Research to Get Major Upgrade with NIH Grant
One of just two National Biocontainment Laboratories in the United States, the NEIDL has just been given a $7.5 million grant from the National Institutes of Health to modernize its facilities and help broaden its impact.
A New Type of RNA Could Revolutionize Vaccines and Cancer Treatments
An accidental discovery turned into an unexpected success, when a team of interdisciplinary BU researchers created a new and improved COVID vaccine.
BU Researchers Join $100 Million Effort to Fight Future Deadly Pathogens
Original article from The Brink by Andrew Thurston. February 17,…
A rare Marburg outbreak sparks a race against time to test vaccines and drugs
Original article from STAT by Helen Branswell. February 14, 2023 A…
NEIDL Researchers Discover New SARS-CoV-2 Weak Spot—Which Could Inspire Improved Vaccines
Original article from The Brink by The Brink Staff. January 11, 2023 Nature publishes BU-led COVID…
BU lab wasn’t required to clear potentially controversial study with NIH, director says
Original article from STAT by Helen Branswell. October 18, 2022…
NEIDL Researchers Refute UK Article about COVID Strain
Original article from The Brink by The Brink Staff. October…
Nancy J. Sullivan Named New NEIDL Director
Original article from The Brink by Andrew Thurston. September 16,…
BU’s Nahid Bhadelia Joins White House COVID-19 Response Team
Original article from The Brink by Andrew Thurston. June 13,…
How Worried Should We Be about Monkeypox? Interview with John H. Connor
Original article from The Brink by Doug Most. May 25 ,…